LSE •
Healthcare •
Biotechnology •
Quote as of 08/07/2026 13:47
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization7.22 mln
Float307 mln
Earnings Date09/24/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
-0.44
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
ROA
-209
Deeply negative
Business Description
Cizzle Biotechnology Holdings Plc is a UK-based company focused on detecting cancer at an early stage. Its primary work centers on a simple blood test designed to identify lung cancer early, using a protein marker called CIZ1B. The company operates out of London.
